abstract |
The present invention is useful in the treatment of diseases and disorders related to CCR5-, such as the inhibition of HIV replication, the prevention or treatment of HIV infection and the treatment of the resulting acquired immune deficiency syndrome (AIDS). Or a pharmaceutically acceptable derivative thereof. |